HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benoit I Giasson Selected Research

Cognitive Dysfunction

1/2023Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis.
1/2020Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benoit I Giasson Research Topics

Disease

70Parkinson Disease (Parkinson's Disease)
01/2023 - 07/2002
58Neurodegenerative Diseases (Neurodegenerative Disease)
09/2023 - 01/2003
45Synucleinopathies
01/2023 - 05/2002
29Alzheimer Disease (Alzheimer's Disease)
10/2023 - 12/2002
23Tauopathies
09/2023 - 01/2003
19Multiple System Atrophy
01/2023 - 07/2003
17Dementia (Dementias)
01/2021 - 12/2002
14Parkinsonian Disorders (Parkinsonism)
01/2017 - 12/2002
12Lewy Body Disease (Lewy Body Dementia)
12/2022 - 05/2008
9Proteostasis Deficiencies
03/2021 - 05/2013
8Disease Progression
01/2021 - 01/2012
7Neuroinflammatory Diseases
01/2022 - 10/2006
7Frontotemporal Dementia (Semantic Dementia)
01/2021 - 05/2013
7Gliosis
01/2020 - 04/2010
5Amyloid Plaque
01/2022 - 01/2003
4Movement Disorders (Movement Disorder)
01/2018 - 05/2002
3Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
10/2023 - 01/2018
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2020 - 08/2013
3Amyloidosis
12/2018 - 01/2003
3Gaucher Disease (Gaucher's Disease)
10/2018 - 11/2010
3Paralysis (Palsy)
11/2017 - 05/2002
3Huntington Disease (Huntington's Disease)
08/2013 - 06/2005
2Pick Disease of the Brain (Pick's Disease)
01/2023 - 01/2023
2Cognitive Dysfunction
01/2023 - 01/2020
2Animal Disease Models
01/2020 - 01/2019
2Prion Diseases (Transmissible Spongiform Encephalopathies)
06/2018 - 07/2014
2Inflammation (Inflammations)
05/2008 - 10/2006
2Mitochondrial Diseases (Mitochondrial Disease)
01/2007 - 12/2004
1Corticobasal Degeneration
01/2023
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
12/2020
1TDP-43 Proteinopathies
11/2020
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
11/2020
1limbic-predominant age-related TDP-43 encephalopathy
11/2020
1Fragile X Tremor Ataxia Syndrome
10/2019
1Scrapie
07/2014
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
07/2014
1Atrophy
04/2010
1Nerve Degeneration
03/2010
1Neuroblastoma
05/2008
1Astrocytoma (Pilocytic Astrocytoma)
10/2006
1Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
01/2004

Drug/Important Bio-Agent (IBA)

53SynucleinsIBA
01/2023 - 02/2011
46Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2003
37alpha-SynucleinIBA
01/2021 - 05/2002
21PrionsIBA
01/2023 - 01/2012
14Amyloid (Amyloid Fibrils)IBA
01/2023 - 01/2003
13tau Proteins (tau Protein)IBA
09/2023 - 01/2003
11AntibodiesIBA
09/2023 - 06/2005
7EpitopesIBA
09/2023 - 12/2013
7Leucine (L-Leucine)FDA Link
12/2013 - 02/2006
5Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021 - 01/2018
5Monoclonal AntibodiesIBA
11/2020 - 11/2003
5Phosphotransferases (Kinase)IBA
01/2018 - 02/2006
4Protein Isoforms (Isoforms)IBA
01/2023 - 01/2018
4Dopamine (Intropin)FDA LinkGeneric
01/2020 - 06/2005
4UbiquitinIBA
01/2020 - 07/2003
4Peptides (Polypeptides)IBA
10/2019 - 01/2003
4Glucosylceramidase (Glucocerebrosidase)IBA
10/2018 - 11/2010
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020 - 07/2003
3polyglutamineIBA
01/2018 - 08/2013
2Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2021
2Apolipoproteins E (ApoE)IBA
01/2023 - 01/2022
2ApolipoproteinsIBA
01/2023 - 01/2022
2Protein AggregatesIBA
01/2022 - 03/2014
2Amyloid beta-PeptidesIBA
12/2020 - 01/2003
2PolymersIBA
01/2020 - 12/2002
2Interleukin-6 (Interleukin 6)IBA
01/2017 - 10/2006
2Protein Deglycase DJ-1IBA
11/2010 - 06/2005
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2007 - 10/2006
1Detergents (Detergent)IBA
10/2023
1VaccinesIBA
01/2023
1Apolipoprotein E4IBA
01/2022
1Apolipoprotein E2IBA
01/2022
1Carisoprodol (Soma)FDA LinkGeneric
01/2022
1Apolipoprotein E3IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
03/2021
1ParaffinIBA
11/2020
1Formaldehyde (Formol)FDA Link
11/2020
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2020
1PhosphoproteinsIBA
01/2019
1ProteomeIBA
12/2018
1LipofuscinIBA
10/2018
1keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
01/2017
1sarkosylIBA
01/2017
1CationsIBA
07/2015
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
12/2013
1P-type ATPasesIBA
12/2012
1ManganeseIBA
10/2011
1EnzymesIBA
11/2010
1Phospho-Specific AntibodiesIBA
05/2008
1PesticidesIBA
02/2007
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2006
1InterleukinsIBA
10/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2006
1NucleotidesIBA
03/2005
1Amyloidogenic ProteinsIBA
06/2004
1beta-SynucleinIBA
05/2004

Therapy/Procedure

12Therapeutics
01/2023 - 05/2010
1Immunotherapy
01/2021
1Injections
01/2017